Patents
Sitemap › C07 - Organic chemistry › C07C - Acyclic or carbocyclic compounds › C07C 311 - Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
Patents for C07C 311 - Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups (17,647)
12/2013
12/17/2013US8609881 Cure accelerators for anaerobic curable compositions
12/12/2013US20130331610 Halogenated Pyrazolo[1,5-A]Pyrimidines, Processes, Uses, Compositions and Intermediates
12/12/2013US20130331609 Production process for fluorosulfonylimide ammonium salt
12/12/2013US20130331456 Inhibitors of viral entry into mammalian cells
12/12/2013US20130331450 Class ii hmg-coa reductase inhibitors and methods of use
12/12/2013US20130331392 Cycloalkyl guanidine f1f0-atpase inhibitors and therapeutic uses thereof
12/11/2013EP2671271A1 Photovoltaic element
12/11/2013CN103443948A 光伏元件 Photovoltaic element
12/11/2013CN103435649A Bidentate phosphine functionalization ionic liquid and synthetic method thereof
12/11/2013CN103435606A CDK2 and CSK3beta dual inhibitor and application thereof
12/11/2013CN103435524A N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors
12/11/2013CN102659646B Method for preparing beta-amino-carbonyl compounds
12/10/2013CA2552317C Hcv ns-3 serine protease inhibitors
12/04/2013CN103420877A Selective hydroxamate-based MMP inhibitors
12/04/2013CN103012224B Production process of medicinal sulphaguanidine
12/04/2013CN101466665B Compositions useful as inhibitors of voltage-gated sodium channels
12/03/2013CA2599411C Enzyme inhibitors
12/03/2013CA2530302C Novel aminobenzophenone compounds
12/03/2013CA2489590C Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
11/2013
11/28/2013WO2013177224A1 N-substituted benzamides and their use in the treatment of pain
11/28/2013WO2013175053A1 Catechol o-methyltransferase activity inhibiting compounds
11/28/2013US20130317007 Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at c-17
11/28/2013US20130317001 N-substituted benzamides and methods of use thereof
11/28/2013US20130317000 N-substituted benzamides and methods of use thereof
11/27/2013CN103415501A Iodoarene derivative, method for producing optically active spirolactone compound using same, and method for producing optically active cyclization adduct
11/27/2013CN102898336B Preparation method of tamsulosin hydrochloride
11/27/2013CN102838514B Synthetic method of hexamethylene flusulfamide
11/27/2013CN102757370B Derivatives of p-aminobenzoic acid and applications thereof
11/21/2013WO2013172412A1 Method for producing sulfonyl amide compound containing fluorinated aliphatic group and method for producing anionic hydrophilic group-containing surfactant
11/21/2013WO2013172190A1 Method for producing imidic acid compound
11/21/2013WO2013171484A1 Crystallisation process
11/21/2013US20130310384 Sulfonamide-Containing Compounds
11/21/2013US20130310347 Multi-modality molecular imaging high-throughput assay for identifying heat shock protein 90 (hsp90) inhibitors
11/20/2013EP2663608A2 Methods for treating siliciclastic hydrocarbon-bearing formations with fluorinated amine oxides
11/20/2013CN103396402A Substituted aminoindanes and analogs thereof, and pharmaceutical use thereof
11/20/2013CN102408285B Method for directly aminating benzyl hydrocarbon of methylbenzene derivative
11/19/2013CA2595889C N-halogenated amino acids and n,n-dihalogenated amino acids in combination with hypohalous acids
11/14/2013US20130303491 Antiviral Drugs for Treatement or Prevention of Dengue Infection
11/13/2013CN103391896A Manufacturing method for fluorosulfonylimide ammonium salt
11/13/2013CN103387524A Preparation method of fomesafen
11/13/2013CN102701989B Method for removing nitrosamine from dinitroaniline herbicides
11/13/2013CN102408286B Preparation method of N,N-disubstituted sulfonamide compound
11/13/2013CN102329255B Process for synthesizing fomesafen through directional nitration
11/13/2013CN101808983B Biaryl sulfonamide derivatives
11/07/2013WO2013163675A1 Substituted 3-haloallylamine inhibitors of ssao and uses thereof
11/06/2013EP2660196A1 Manufacturing method for fluorosulfonylimide ammonium salt
11/06/2013CN103384662A Novel 1,2-bis-sulfonamide derivatives as chemokine receptor modulators
11/06/2013CN102365266B Fluorine-containing n-alkyl sulfonyl imide compound, manufacturing method therefor, and method of manufacturing an ionic compound
11/05/2013CA2481202C Functionalized ionic liquids, and methods of use thereof
10/2013
10/31/2013WO2013161980A1 Cyclohexanediamide derivative and use thereof for medical purposes
10/31/2013WO2013160418A1 Novel compounds
10/31/2013US20130289280 Novel pharmaceutical forms, and methods of making and using the same
10/30/2013CN103380115A Sulfur derivatives as chemokine receptor modulators
10/30/2013CN103373939A 4-methoxy-N, N'-bisubstituted phenyl-1, 3-benzene diamide compounds as well as preparation method and application thereof
10/30/2013CN103373938A 4-ethoxy-1,3-phenylenedimethylene amide compounds as well as preparation methods and applications thereof
10/30/2013CN102153483B Axial chirality vicinal diamine compound and preparation method thereof
10/30/2013CN101768149B Beta- aminoketone (alkamine) derivatives and use thereof
10/30/2013CN101747244B Method for synthesizing perfluoroalkyl sulfimide alkali metal salt and ionic liquid synthesized by same
10/29/2013US8569543 CCR9 inhibitors and methods of use thereof
10/29/2013US8569378 p27 protein inducer
10/24/2013WO2013157955A1 Geranyl geranyl acetone analogs and uses thereof
10/24/2013WO2013157926A1 Geranyl geranyl acetone analogs and uses thereof
10/23/2013EP2651901A1 Novel 1,2- bis-sulfonamide derivatives as chemokine receptor modulators
10/23/2013EP2651893A1 Sulfur derivatives as chemokine receptor modulators
10/23/2013CN103360341A Tertiary leucine derived chiral amine compound as well as preparation method and application thereof
10/23/2013CN103360270A Serine derived chiral amine compound as well as preparation method and application thereof
10/22/2013CA2599169C Synthesis of (e)-alpha, beta unsaturated sulfides, sulfones, sulfoxides and sulfonamides
10/22/2013CA2577309C Alpha, beta-unsaturated sulfones, sulfoxides, sulfonimides, sulfinimides, acylsulfonamides and acylsulfinamides and therapeutic uses thereof
10/17/2013US20130274463 Process and intermediates for preparing macrolactams
10/15/2013US8557872 Compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist; and pharmaceutical compositions containing the same
10/15/2013US8557499 Actinic-ray- or radiation-sensitive resin composition, compound and method of forming pattern using the composition
10/10/2013WO2013149349A1 Ionic compounds having a silyloxy group
10/09/2013CN103347811A Process for production of fluorosulfonylimide ammonium salt
10/09/2013CN102351621B Method for preparing N-sulfonyl amidine
10/08/2013US8552050 Activators of pyruvate kinase M2 and methods of treating disease
10/08/2013CA2473938C Human adam-10 inhibitors
10/03/2013US20130261178 Phenoxypropanol derivatives and their use in treating cardiac and cardiovascular diseases
10/03/2013US20130261133 Therapeutic Compounds for Protozoal and Microbial Infections and Cancer
10/03/2013US20130261132 Calcium-sensing receptor-active compounds
10/03/2013US20130261120 Substituted n-(2-arylamino)aryl sulfonamide-containing combinations
10/03/2013US20130261052 Inhibition of memapsin 1 cleavage in the treatment of diabetes
10/02/2013EP2643290A1 Calcium-sensing receptor-active compounds
10/02/2013CN101360706B (R)-arylalkylamino derivatives and pharmaceutical compositions containing them
10/01/2013US8546602 5,6-D hydro-1H-pyridin-2-one compounds
10/01/2013CA2589495C 2-arylpropionic acid derivatives and pharmaceutical compositions containing them
09/2013
09/26/2013WO2013140347A1 Sulphonamide derivatives of benzylamine for the treatment of cns diseases
09/26/2013US20130253053 Method of Treating Skin with microRNA Modulators
09/26/2013US20130252984 Sulfur derivatives as chemokine receptor modulators
09/26/2013US20130251673 Hepatitis b antiviral agents
09/25/2013CN103328439A Method for producing fluoroamine
09/25/2013CN103319381A Preparation method of high-purity fine sulfanilamide
09/24/2013US8541632 Process and apparatus for producing chlorohydrin
09/24/2013US8541410 Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them
09/24/2013CA2611609C Ampa receptor potentiators
09/19/2013US20130245018 Aryl-Phenyl-Sulfonamido-Cycloalkyl Compounds and Their Use
09/18/2013CN102153481B Application of thionyl chloride and alcohol as selective deacylation reagents for N-aryl fatty amide or N-heterocyclic fatty amide
09/17/2013CA2521883C Indene derivatives as pharmaceutical agents
09/12/2013US20130237702 Alkylamine derivative
09/12/2013US20130237542 Aryloxy phenoxy acrylic compound having hif-1 inhibition activity, method for preparing same, and pharmaceutical composition containing same as an active ingredient
09/12/2013US20130236969 Use of Compounds for Inducing Differentiation of Mesenchymal Stem Cells to Chondrocytes
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 ... 177